TL;DR: Green Thumb Industries (GTBIF) closed Wednesday at $7.60 on the OTCQX, sitting at roughly 48 cents on the dollar relative to the analyst consensus price target of $15.67. With Q1 FY26 revenue at $300 million and a trailing P/E of 14.90, GTBIF remains the rare profitable MSO in a sector where most operators still report net losses. The next major catalyst arrives August 4 when the company reports Q2 FY26 results.
Market Analysis
As Wednesday’s session wound down across U.S. equity markets, Green Thumb Industries continued to trade in a band that technical analysts describe as consolidation territory — holding above its 52-week low of $5.29 but still roughly 27% below its 52-week high of $10.43. At $7.60 on the OTCQX, the stock carries a market capitalization of approximately $1.66 billion and an enterprise value of $1.95 billion.
What distinguishes GTBIF from nearly every other operator in its peer group is straightforward: it makes money. The trailing 12-month earnings per share of $0.51 and a P/E ratio of 14.90 put Green Thumb in a category that most cannabis investors rarely encounter — a sector constituent with a positive price-to-earnings multiple. Net income attributable to common shareholders over the trailing 12 months reached $121.24 million on revenue of approximately $1.2 billion, producing a profit margin of 10.14%.
That profitability has attracted sustained analyst attention. The Wedbush team maintained an Outperform rating while raising its price target from $15 to $16 in May 2024 — a target implying more than 100% upside from current levels. The consensus average of $15.67 across all covering analysts tells a similar story: the market is either discounting significant regulatory or operational risk, or there is a meaningful pricing inefficiency in an OTC-listed name that institutional capital cannot fully access due to exchange restrictions on cannabis equities.
Volume patterns suggest the stock remains in an accumulation phase rather than a breakout. Wednesday’s session of approximately 44,000 shares traded compares against an average daily volume of 531,570 — light conditions that typically precede a catalyst event rather than signal distribution pressure.
Regulatory and Market Context
The Schedule III reclassification of cannabis under the Controlled Substances Act remains the single most consequential near-term catalyst for operators like Green Thumb. While the DEA’s proposed rulemaking has progressed through the administrative comment period, formal implementation timelines remain uncertain as of late July 2026. The principal near-term impact for GTBIF would be relief from Internal Revenue Code Section 280E — the provision preventing cannabis businesses from deducting ordinary business expenses against gross income, which historically inflates effective tax rates well above standard corporate rates.
For a company already generating positive GAAP net income under 280E constraints, the elimination of that provision could be materially accretive to earnings per share. Green Thumb has previously indicated that 280E exposure represents one of its most significant operational headwinds. Any rescheduling clarity before fiscal year-end would recalibrate earnings expectations across the sector.
Green Thumb’s 18-state operational footprint includes Illinois, Pennsylvania, Ohio, Minnesota, Nevada, and New Jersey — markets where adult-use legalization is either firmly established or gaining consumer adoption momentum. Unlike single-state operators, the multi-state model provides geographic diversification against localized pricing compression and regulatory reversals, a structural advantage that contributed to the company’s consistent profitability even through cannabis sector headwinds in 2023 and 2024.
Looking across the peer landscape entering Thursday: Curaleaf Holdings (CURLF) approaches its August 5 earnings window with a 158% one-year gain but no current P/E ratio due to ongoing net losses. Tilray Brands (TLRY), which reports first on July 28, trades at $4.26 near its 52-week low of $4.20, reflecting investor skepticism about the company’s hybrid cannabis-beer growth strategy. Canopy Growth (CGC) lingers below $0.94 ahead of its estimated August 7 report. Against this backdrop, GTBIF’s demonstrated profitability stands as a structural differentiator heading into what analysts expect to be the sector’s most closely watched earnings sprint of 2026.
Conclusion: What to Watch Thursday and Into August 4
Thursday’s session will offer the sector its first read on whether pre-earnings accumulation translates into elevated volume for GTBIF. With the Q2 FY26 report arriving August 4, investors will be monitoring whether sell-side analysts revise guidance ahead of the print — particularly around Q2 revenue trends in Illinois and Ohio, two of Green Thumb’s highest-volume markets.
The bull case entering the earnings window is straightforward: GTBIF is a profitable, multi-state cannabis operator trading at approximately 48% of analyst consensus. Whether the August 4 report confirms that thesis depends on three data points — revenue versus the estimated Q2 range of $305–315 million, operating margin trajectory relative to Q1’s 10.14%, and any forward commentary on the 280E exposure should Schedule III become effective before December 31, 2026.
Investors tracking the broader sector can monitor price and volume action across GTBIF, CURLF, TLRY, and CGC in real time using the cannabis stock tracker — a useful reference as the earnings window opens over the next 16 days.